Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024

Go back to Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024
(NASDAQ: VRDN) Delayed: 22.00 +0.07 (0.32%)
Previous Close $21.93    52 Week High
Open $21.99    52 Week Low
Day High $22.17    P/E N/A 
Day Low $21.80    EPS
Volume 5,381,486